| Bioactivity | Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain[1]. |
| Target | SARS-CoV2 |
| Name | Crexavibart |
| CAS | 2599039-61-7 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |